4554.T
Price:
$1329
Market Cap:
$32.46B
Fuji Pharma Co., Ltd. engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally. The company offers injection agents, internal drugs, drugs for external use, and diagnostic products. It also provides medical care for women; in vitro diagnostics, acute medical care products, and curative medicines; and information regarding pharmaceuticals and health. Fuji Pharma Co., Ltd. was incorporated in 1965 and is headquartered in Tokyo, Japan.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2010-02-22
Stock Exchange
JPX
Ticker
4554.T
According to Fuji Pharma Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 10.18. This represents a change of -29.05% compared to the average of 14.35 of the last 4 quarters.
The mean historical PE Ratio of Fuji Pharma Co., Ltd. over the last ten years is 13.45. The current 10.18 PE Ratio has changed 7.47% with respect to the historical average. Over the past ten years (40 quarters), 4554.T's PE Ratio was at its highest in in the September 2022 quarter at 174.63. The PE Ratio was at its lowest in in the September 2021 quarter at -43.61.
Average
13.45
Median
14.07
Minimum
5.03
Maximum
18.93
Discovering the peaks and valleys of Fuji Pharma Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 37.50%
Maximum Annual PE Ratio = 18.93
Minimum Annual Increase = -38.97%
Minimum Annual PE Ratio = 5.03
Year | PE Ratio | Change |
---|---|---|
2024 | 5.03 | -38.97% |
2023 | 8.25 | -11.46% |
2022 | 9.32 | -27.91% |
2021 | 12.93 | -30.75% |
2020 | 18.66 | 37.50% |
2019 | 13.57 | -14.27% |
2018 | 15.83 | -9.04% |
2017 | 17.41 | -8.07% |
2016 | 18.93 | 30.07% |
2015 | 14.56 | 0.68% |
The current PE Ratio of Fuji Pharma Co., Ltd. (4554.T) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
7.53
5-year avg
10.84
10-year avg
13.45
Fuji Pharma Co., Ltd.’s PE Ratio is less than Sumitomo Pharma Co., Ltd. (16.49), less than Torii Pharmaceutical Co., Ltd. (32.03), greater than Zeria Pharmaceutical Co., Ltd. (9.09), greater than Towa Pharmaceutical Co., Ltd. (7.66), greater than Daito Pharmaceutical Co.,Ltd. (7.04),
Company | PE Ratio | Market cap |
---|---|---|
16.49 | $389.74B | |
32.03 | $177.94B | |
9.09 | $90.27B | |
7.66 | $145.37B | |
7.04 | $30.47B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Fuji Pharma Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Fuji Pharma Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Fuji Pharma Co., Ltd.'s PE Ratio?
How is the PE Ratio calculated for Fuji Pharma Co., Ltd. (4554.T)?
What is the highest PE Ratio for Fuji Pharma Co., Ltd. (4554.T)?
What is the 3-year average PE Ratio for Fuji Pharma Co., Ltd. (4554.T)?
What is the 5-year average PE Ratio for Fuji Pharma Co., Ltd. (4554.T)?
How does the current PE Ratio for Fuji Pharma Co., Ltd. (4554.T) compare to its historical average?